These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1365589)

  • 21. Imipenem-cilastatin.
    Dinsmoor MJ
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):475-82. PubMed ID: 1436925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of IPM/CS in gram-negative bacillus infections: use of an endotoxin-specific assay.
    Endo S; Inada K; Inoue Y; Yamada Y; Fujii N; Nagasawa T; Kikuchi M; Taki K; Hoshi S; Yoshida M
    Clin Ther; 1990; 12(4):352-6. PubMed ID: 2224949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of imipenem-cilastatin in acute ORL infections].
    Cerqua N; Tirelli GC; Piccirillo E
    Riv Eur Sci Med Farmacol; 1992; 14(6):409-10. PubMed ID: 1308610
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
    Chen CH; Lin CH; Lin JS
    Rev Inst Med Trop Sao Paulo; 2017 Jun; 59():e26. PubMed ID: 28591254
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of imipenem-cilastatin in pediatrics.
    Overturf GD
    Pediatr Infect Dis J; 1989 Nov; 8(11):792-4. PubMed ID: 2687788
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.
    Hartenauer U; Weilemann LS; Bodmann KF; Ritzerfeld WW; Asmus S; Koch EM
    J Hosp Infect; 1990 Apr; 15 Suppl A():61-4. PubMed ID: 1971647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipenem/cilastatin in the treatment of severe nosocomial pneumonia.
    Potgieter PD; Linton DM; Forder AA; Plumb H
    S Afr Med J; 1988 Oct; 74(8):390-2. PubMed ID: 3187816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges in the design of trials to evaluate antibacterial agents in serious infections.
    Norrby SR
    J Hosp Infect; 1990 Apr; 15 Suppl A():13-21. PubMed ID: 1971640
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetic evidence of imipenem efficacy in the treatment of Klebsiella pneumoniae nosocomial meningitis.
    Aubert G; Jacquemond G; Pozzetto B; Duthel R; Boylot D; Brunon J; Dorche G
    J Antimicrob Chemother; 1991 Aug; 28(2):316-7. PubMed ID: 1778864
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug therapy during continuous arteriovenous hemofiltration.
    Keller E
    Adv Exp Med Biol; 1989; 260():117-27. PubMed ID: 2696363
    [No Abstract]   [Full Text] [Related]  

  • 31. [2 cases of spontaneous pneumothorax due to acute nosocomial bilateral staphylococcal bronchopneumonia].
    Gnarini R; Guerriero M; Postiglione A; Smeraglia R; Conte M; Galderisi P; Soscia M
    G Ital Chemioter; 1991; 38(1-3):145-6. PubMed ID: 1365570
    [No Abstract]   [Full Text] [Related]  

  • 32. Changing role of carbapenems in the treatment of lower respiratory tract infections.
    Lode H; Hamacher J; Eller J; Schaberg T
    Scand J Infect Dis Suppl; 1995; 96():17-23. PubMed ID: 7652498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Imipenem-cilastatin in nosocomial infections in HIV+ patients].
    Pagano G; Repetto T; Ferrazin A; Canessa A; Carrega G
    G Ital Chemioter; 1991; 38(1-3):191-2. PubMed ID: 1365589
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy of imipenem-cilastatin in combined therapy of severe anaerobic-aerobic infection of bones and soft tissues].
    Goriunov SV; Romashov DV; Butivshchenko IA; Il'ianina AA; Mikhal'skiĭ VV; Rog AA; Polikarpova SV
    Khirurgiia (Mosk); 2002; (7):50-6. PubMed ID: 12162087
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical evaluation of imipenem/cilastatin in the therapy of severe infections in high-risk patients.
    Cristiano P
    Drugs Exp Clin Res; 1989; 15(1):17-20. PubMed ID: 2743870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
    Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.